Tresivac (mmr)-0.5ml Inj.
Manufactured By
Serum Institute Of India Ltd
INDICATION
For active immunization against Measles and Rubella in infants, children, adolescents and young adults at risk.
ROUTE OF ADMINISTRATION
Subcutaneous injection
DOSE
First dose of MMR given in children - 12 months of age to10 years of age.
Second dose of MMR is advocated any time before the age of 6 years (elementary school entry 4-6 years) and thereafter Measles and Rubella vaccine is recommended.
COMPOSITION
The reconstituted vaccine contains in each single human dose of 0.5 ml:
Not less than 1000 CCID50 of Measles virus
Not less than 5000 CCID50 of Mumps virus
Not less than 1000 CCID50 of Rubella virus
PRESENTATION:
1 Dose vial with diluent (0.5 ml)
2 Dose vial with diluent (1 ml)
5 Dose vial with diluent (2.5 ml)
10 Dose vial with diluent (5 ml)